An official website of the United States government
Home
Name
ECX
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for ECX
Name
Alternate Names
4'-Epiadriamycin Hydrochloride
4'-Epidoxorubicin
4-EA
Ellence
Epidoxorubicin
Epidoxorubicin Hydrochloride
Epirubicin Hydrochloride
IMI-28
Pharmorubicin
Pidorubicin Hydrochloride
Abbreviations
EPI
epi-ADR
Category
Chemotherapy
Subcategory
Anthracycline
Antitumor antibiotic
NSC Number
256942
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum
Abbreviations
CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
119875
Primary Site
Histology
None
Remarks
An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.
Coding
This drug should be coded
Name
Alternate Names
Ro 091978
Ro-09-1978
Ro-091978
Xeloda
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
712807
Primary Site
Histology
None
Remarks
FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.
Coding
This drug should be coded
